The incidence and mortality of small-cell lung cancer worldwide make this disease a notable
health-care issue. Diagnosis relies on histology, with the use of immunohistochemical …

Small-cell lung carcinoma is an aggressive form of lung cancer that is strongly associated
with cigarette smoking and has a tendency for early dissemination. Increasing evidence has …

Comments on the changes that have taken place in the past two decades in the treatment of
patients with small-cell lung cancer (SCLC). The introduction of cytotoxic drugs into …

Small cell lung cancer accounts for approximately 15% of bronchogenic carcinomas. It is the
cancer most commonly associated with various paraneoplastic syndromes, including the …

Purpose The American College of Chest Physicians (ACCP) produced an evidence-based
guideline on treatment of patients with small-cell lung cancer (SCLC). Because of the …

Small cell lung cancer accounts for 13–15% of all lung cancer worldwide. There has been a
decrease in the number of cases, with no clear explanation, except probably to changing in …

Small cell lung cancer (SCLC) is an aggressive disease that accounts for approximately
14% of all lung cancers. In the United States, approximately 31,000 patients are diagnosed …

An estimated 1.6 million new lung cancers are diagnosed worldwide each year. The highest
incidence rates in males are observed in Central/Eastern and Southern Europe (57 and 49 …

Although small-cell lung cancer (SCLC) makes up a smaller proportion of all lung cancers
than it did 25 years ago, it remains a common cause of cancer mortality that requires more …

Small cell lung cancer (SCLC) occurs almost exclusively in smokers and represents 15 to
25% of all lung cancer histologic findings. It is distinguished from non-small cell lung cancer …